By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Proteros Biostructures today said that it has entered into a drug discovery services agreement with the CHDI Foundation, a non-profit scientific organization focused on discovering and developing Huntington's disease therapies.

Under the alliance, Martinsried, Germany-based Proteros will provide structure-based drug discovery services to CHDI using its integrated discovery platform including proprietary X-ray crystallography tools.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.